Xeris Biopharma (Nasdaq: XERS) A biopharmaceutical company developing and commercializing unique therapies for patient populations in endocrinology, neurology, and gastroenterology February 2022 Copyright ©2017-2021 Xeris Pharmaceuticals, Inc. All rights reserved. Forward-looking statements 2 Any statements in this presentation about future expectations, plans and prospects for Xeris Biopharma Holdings, Inc. including statements regarding the market and therapeutic potential of its products and product cand ...